Prioritise safety when considering weight-loss injections
Growing public interest in injectable weight-loss medicines, including semaglutide products, has highlighted the importance of patient awareness, appropriate medical oversight and the use of medicines supplied through the formal regulatory framework. Recent regulatory concerns in South Africa have drawn attention to the potential risks associated with unregistered or improperly supplied GLP-1/GIP injectable products, particularly where […]
Prioritise safety when considering weight-loss injections Read More »










